AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 48 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,463,009 | -24.0% | 181,504 | -3.9% | 0.00% | – |
| Q2 2023 | $3,239,189 | -13.0% | 188,874 | +2.3% | 0.00% | – |
| Q1 2023 | $3,723,241 | -66.9% | 184,593 | -52.0% | 0.00% | – |
| Q4 2022 | $11,261,982 | +292.3% | 384,368 | +121.9% | 0.00% | – |
| Q3 2022 | $2,871,000 | +2.9% | 173,178 | -3.0% | 0.00% | – |
| Q2 2022 | $2,791,000 | -9.4% | 178,554 | +6.3% | 0.00% | – |
| Q1 2022 | $3,080,000 | +69.4% | 168,037 | +9.0% | 0.00% | – |
| Q4 2021 | $1,818,000 | -31.1% | 154,224 | +22.6% | 0.00% | – |
| Q3 2021 | $2,640,000 | – | 125,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
| TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
| Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
| Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
| Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
| RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
| Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
| VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
| Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
| Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |